This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


AbbVie Inc.

Drug Names(s): ABT-122

Description: ABT-122 is a dual-variable domain Ig (DVD-Ig) that targets tumor necrosis factor (TNF) and interleukin 17 (IL-17). DVD-Ig is a proprietary Abbott technology representing an innovative approach that can target multiple disease-causing antigens with a single biologic agent.

ABT-122 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug